Results 131 to 140 of about 20,412 (204)

Dopamine Receptor Modulation in Co-Occurring Disorders: Potential of Cariprazine and D3 Receptor Activity. [PDF]

J Dual Diagn
Lynch ST, Mariani JJ, Levin FR.
europepmc   +1 more source

Kava (<i>Piper methysticum</i> G. Forst) for Substance Use Disorders: A Review of Mechanism, Pharmacology, Clinical Evidence, and Therapeutic Potential. [PDF]

Nutrients
Krehl J, Mamallapalli JN, Xing C, Grundmann O.   +3 more
europepmc   +1 more source

Addiction as a cardiometabolic disease: a neurocardiometabolic framework and the emerging role of GLP-1 receptor therapies. [PDF]

Eur Heart J Open
Seijas-Amigo J, Salgado-Barreira Á, Eiras S, Arias-Rivas S, Rodriguez-Carnero G, Rodriguez-Mañero M, Gonzalez-Juanatey JR.   +6 more
europepmc   +1 more source

Examining Within-Session and Between-Session Change in Exposure-Meal-Related Distress During Intensive Outpatient Treatment for Eating Disorders. [PDF]

Int J Eat Disord
Walker DC, Chen M, Reilly EE, Morison J, Anderson LM.   +4 more
europepmc   +1 more source

Incidence of substance use disorders and comorbidities in the All of Us Research Program. [PDF]

Drug Alcohol Depend
Parker MA, Ahmedani BK, Yeh HH.
europepmc   +1 more source

The demand-side challenges in public mental health: A narrative study in a rural South Indian community. [PDF]

Indian J Psychiatry
Mittal A, Nirisha L, Kumar CN, Kulal N, Satish S, Harshitha NR, Patley R, Malathesh BC, Ibrahim FA, Manjunatha N, Parthasarathy R, Manjappa AA, Thirthalli J, Chand PK, Arora S, Math SB.   +15 more
europepmc   +1 more source